EphA2 and EphA3 are commonly expressed in GBM, including in regions of tumor neovasculature, tumor-associated immune cells, and tumor-infiltrating cells (126), and associated with poorer outcomes in GBM patients (127). The gene discussed is EPHA3; the disease is glioblastoma.